Nancy S Gavert

11PUBLICATIONS
96CO-AUTHORS
Molecular targetsMicrobial ecologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer Treatment.

|Nov 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures.

Elinor Gigi, Nancy Gavert, Lilach Raijman-Nagar

|Nov 08, 2024
A Necessary Role for Cyclin D2 Induction During Colon Cancer Progression Mediated by L1.

Arka Saha, Nancy Gavert, Thomas Brabletz

|Sep 09, 2023
An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1.

Arka Saha, Nancy Gavert, Thomas Brabletz

|Jul 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.

Chani Stossel, Maria Raitses-Gurevich, Dikla Atias

|Feb 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.

Nancy Gavert, Yaara Zwang, Roi Weiser

Pageof 2

Frequent Collaborators

7 joint publications

Ravid Straussman

2 joint publications

Leore T Geller

2 joint publications

Deborah Nejman

2 joint publications

Zachary A Cooper